07:37 AM EDT, 06/05/2024 (MT Newswires) -- Aurora Cannabis ( ACB ) , a Canada-based global medical cannabis company, on Wednesday reported the launch of its 1.2-gram resin cartridges in Australia.
MedReleaf Australia will distribute the new resin cartridges, which have been developed and manufactured at Aurora's EU-GMP and TGA-GMP certified facility.
The new resin cartridges include offerings from Aurora and IndiMed.
On Tuesday, Aurora's stock fell 2% in U.S. trading and dropped 1.8% in Canada. On Wednesday, the stock rose 0.5% in pre-market U.S. trading.